Gladstone-UCSF Institute of Genomic Immunology Seminar
Hongbo Chi, PhD
Groundbreaking and innovative, Hongbo Chi’s research aims to understand immune signaling and cell metabolism that control the differentiation and function of immune cells and the effects on immune-mediated disorders. His laboratory has discovered the critical importance of mTOR signaling, metabolism, and autophagy in the differentiation and function of T cells, the control of T cell quiescence and antigen-triggered exit from quiescence, and the regulation of autoimmune, infectious, and malignant diseases.
His research has also contributed to the understanding of the signaling and metabolic pathways in dendritic cell biology and the crosstalk between innate and adaptive immunity. His efforts have yielded the Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation, the Mentored Research Scientist Development Award from the National Institute of Health, and Scholar Awards from both the American Cancer Society and the American Asthma Foundation.
Chi is a professor in the Department of Immunology at St. Jude Children’s Research Hospital in Memphis, Tennessee, where he has been since 2007. He is also Robert G. Webster Endowed Chair in Immunology, Co-Director at the Center of Excellence for Pediatric Immuno-Oncology (CEPIO), and Associate Director of Basic Research in the Comprehensive Cancer Center at St. Jude. He earned his Master’s degree in pathology in 1998 and his doctorate degree in pathology in 2001, both from the University of Rochester School of Medicine and Dentistry. While at the University of Rochester, Chi held a Robert and Mary Sproull University Fellowship. He then served as a postdoctoral fellow and associate research scientist in Immunobiology at Yale University School of Medicine.
Details
Dates
March 11, 2025Time
10:00-11:00am PDTLocation
Mahley Auditorium & OnlineAudience
Gladstone and UCSFThe Gladstone-UCSF Institute of Genomic Immunology Seminar Series showcases speakers at the intersection of genomic technology and immunology research with an aim to engineer the human immune system for therapeutic benefit. Speakers span technology development, synthetic biology, bioengineering, and the development and clinical application of immunotherapy. These talks are open to the Gladstone and UCSF communities.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.